Using analysis from an open-label, long-term treatment study of the RNS ® System, Rapport will present key new data on the correlation between the reduction in long episode (LE) frequency (abnormal ...
Participants were broken into two cohorts. The first cohort received one of three doses of PCRX-201. The second cohort received concurrent pretreatment with an intraarticular corticosteroid ...
Nipocalimab was granted U.S. FDA Breakthrough Therapy Designation for the treatment of adults living with moderate-to-severe Sjögren's disease based on results from the Phase 2 DAHLIAS study ...
production and commercialization of recombinant therapeutic proteins produced by its proprietary ProCellEx ® plant cell-based protein expression system, today reported financial results for the ...
These delicious high-protein dinner recipes feature seasonal ingredients and are great options for those following a diabetes ...
Nov. 14, 2024 /PRNewswire/ -- Nasoya, the nation's leading brand of tofu and pioneer in plant-based foods, today announces a new culinary ... including seven accepted abstracts for poster presentation ...
Regulators are reviewing what could become a multi-billion-dollar drug.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback